DGIST Scholar: 정병혁

정병혁

Jung, Byunghyuck

Researcher ID ORCiD Scopus Google Scholar ">Research Gate

Asymmetric Organic Synthesis and Drug Synthesis Laboratory: Most of drugs, including Remdesivir® as a potential candidate for COVID-19, have chiral carbon-centers and Thalidomide-scandal had brought the importance of stereoselective synthesis of drugs. In this sense, we pursue the development of practical and efficient asymmetric reactions to apply for the lab-scale or bulk-scale synthesis of chiral drugs. To realize that, we focus on 1) the design and the synthesis of novel chiral catalysts, 2) the development of practical reagents, and 3) the development of novel methodology for C-C, C-O, C-N, or C-B bond formations.

미래유망 신기술(6T)

국가과학기술표준분류